A Multicenter Randomized Trial Comparing IM Nails and Plate Fixation in Proximal Tibial Fractures
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00429585 |
|
Recruitment Status :
Completed
First Posted : February 1, 2007
Last Update Posted : January 11, 2021
|
Sponsor:
Boston Medical Center
Collaborator:
Orthopaedic Trauma Association
Information provided by (Responsible Party):
Boston Medical Center
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Brief Summary:
This study looks at two types of surgical treatments and hopes to answer the question: which is the best way to surgically treat a proximal tibia fracture? Both procedures being studied are standard of care (used routinely) and use FDA approved devices. All medical and surgical treatment will be the same for participants as non-participants.
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Tibial Fractures | Device: reamed, interlocking intramedullary nail Device: locking periarticular plate | Not Applicable |
The study is a multicenter randomized controlled trial in which individuals sustaining a fracture of the proximal metaphysis of the tibia will be operatively managed by one of two strategies. The first strategy involves fixation of the fracture with a reamed, interlocking intramedullary nail (Nail Group). The second treatment strategy involves open reduction and internal fixation of the fracture with a locking periarticular plate (Plate Group). The null hypothesis of the study is that there will be no difference in the two groups with respect to the primary and secondary outcome measures. To the degree possible, patients in the two groups will receive post-operative care according to the same standards and protocols.
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 108 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Treatment |
| Official Title: | Intramedullary Nail Versus Plate Fixation Re-Evaluation Study in Proximal Tibial Fractures: A Multicenter Randomized Trial Comparing IM Nails and Plate Fixation (IMPRESS) |
| Actual Study Start Date : | February 2007 |
| Actual Primary Completion Date : | November 30, 2020 |
| Actual Study Completion Date : | December 16, 2020 |
Resource links provided by the National Library of Medicine
| Arm | Intervention/treatment |
|---|---|
|
Randomized Treatment - Nail
Randomized Treatment - Nail
|
Device: reamed, interlocking intramedullary nail
Standard of care device for tibia fracture repair; Randomized Treatment - Nail |
|
Randomized Treatment - Plate
Randomized Treatment - Plate
|
Device: locking periarticular plate
Standard of care device for tibia fracture repair; Randomized Treatment - Plate |
Primary Outcome Measures :
- SF-12v2 [ Time Frame: pre-Op, 3, 6, 12, & 24 month follow-up ]
- EQ-5D [ Time Frame: pre-Op, 3, 6, 12, & 24 month follow-up ]
- SMFA [ Time Frame: pre-Op, 3, 6, 12, & 24 month follow-up ]
- Knee Society Score [ Time Frame: 3, 6, 12, & 24 month follow-up ]
- Clinical Assessment [ Time Frame: 2, 3, 6, 12, & 24 month follow-up ]
Secondary Outcome Measures :
- Re-operation (secondary procedures) [ Time Frame: Up to 24 months post-op ]
- nonunion [ Time Frame: Until radiographically healed ]
- superficial infection rates (wound only) [ Time Frame: Up to 24 months post op ]
- deep infection (bone implant interface) [ Time Frame: Up to 24 months post op ]
- compartment syndrome [ Time Frame: Up to 24 months post op ]
- malunion (>5 degrees varus/valgus) [ Time Frame: Up until radiographically healed ]
- >5 degrees anterior or posterior angulation [ Time Frame: Up until radiographically healed ]
- >10 malrotation degrees, and >1cm shortening) [ Time Frame: Up until radiographically healed ]
- knee range of motion [ Time Frame: Up to 24 months post op ]
Information from the National Library of Medicine
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Skeletally mature,
- Extra-articular fracture of the proximal tibia extending into the metaphyseal with or without intra-articular extension not requiring open reduction with complete AP and lateral radiographs,
- Major fracture line not closer than 4cm from the proximal tibial articular surface
- Fracture requiring operative treatment amenable to either IM nail or plate
- Surgeon agreed to randomize patient
- Informed consent obtained
- Patient is English speaking
Exclusion Criteria:
- Tibial shaft fractures not amenable to intramedullary nailing (i.e.fracture is less than 4 cm from joint surface),
- Fracture of the proximal tibia with intraarticular extension requiring open reduction,
- Known metabolic bone disease
- Separate displaced tibial tubercle fragment,
- Soft tissue injuries compromising treatment method with nail,plate or both.
- Fractures with vascular injury (Gustillo Type IIIC injury) requiring repair,
- Compartment syndrome of the leg diagnosed preoperatively,
- Pathological fractures,
- Retained hardware or existing deformity in the affected limb that would complicate IM nailing,plating or both,
- Symptomatic knee arthritis.
- Surgical delay greater than 3 weeks for closed fractures or 24 hours for open fractures,
- Immunocompromised,
- Unable to comply with postoperative rehabilitation protocols or instructions (i.e. head injured or mentally impaired),
- Current or impending incarceration,
- Unlikely to follow-up in surgeon's estimation.
Information from the National Library of Medicine
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00429585
Locations
Show 29 study locations
Sponsors and Collaborators
Boston Medical Center
Orthopaedic Trauma Association
Investigators
| Principal Investigator: | Paul Tornetta, M.D. | Boston University |
| Responsible Party: | Boston Medical Center |
| ClinicalTrials.gov Identifier: | NCT00429585 |
| Other Study ID Numbers: |
H-25923 |
| First Posted: | February 1, 2007 Key Record Dates |
| Last Update Posted: | January 11, 2021 |
| Last Verified: | January 2021 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | Yes |
Keywords provided by Boston Medical Center:
|
tibia fracture proximal tibia interlocking intramedullary nail |
locking periarticular plate open reduction internal fixation |
Additional relevant MeSH terms:
|
Fractures, Bone Tibial Fractures Wounds and Injuries Leg Injuries |